SCHEMBL587047

SCHEMBL587047

CCC(N)C(=O)O.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78599 0.97
SCHEMBL15355765 0.97
SCHEMBL2050880 0.97 SLC1A2 (0.61)
Hydrogen Peroxide SCHEMBL2783488 0.97
SCHEMBL23958 0.97
SCHEMBL427560 0.97
SCHEMBL587531 0.94
SCHEMBL15820001 0.94
Bromide SCHEMBL11723723 0.94
SCHEMBL16177042 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9339481-B2 Phosphate-binding magnesium salts and uses thereof CYPRESS PHARMACEUTICALS, INC. (US) 2016-05-17 US claimed
US-20150320795-A1 COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY WARSAW ORTHOPEDIC INC. 2015-11-12 US claimed
EP-2931292-A1 COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY Warsaw Orthopedic, Inc. (US) 2015-10-21 EP claimed
WO-2014093918-A1 COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY WARSAW ORTHOPEDIC, INC. (US) 2014-06-19 WO claimed
EP-2416786-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF Cypress Pharmaceutical, Inc. (US) 2012-02-15 EP claimed
US-20110045063-A2 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2011-02-24 US claimed
WO-2010117370-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICALS, INC. (US) 2010-10-14 WO claimed
US-20090269399-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2009-10-29 US claimed
US-20180161365-A1 Phosphate-Binding Magnesium Salts And Uses Thereof CURRAX PHARMACEUTICALS LLC 2018-06-14 US disclosed
EP-2931292-B1 COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY WARSAW ORTHOPEDIC INC (US) 2018-06-13 EP disclosed
US-9889157-B2 Phosphate-binding magnesium salts and uses thereof CYPRESS PHARMACEUTICALS, INC. (US) 2018-02-13 US disclosed
US-20170202875-A1 Phosphate-Binding Magnesium Salts And Uses Thereof WILMINGTON SAVINGS FUND SOCIETY, FSB 2017-07-20 US disclosed
US-9610267-B2 Phosphate-binding magnesium salts and uses thereof CYPRESS PHARMACEUTICALS, INC. (US) 2017-04-04 US disclosed
US-20160256420-A1 Phosphate-Binding Magnesium Salts And Uses Thereof WILMINGTON SAVINGS FUND SOCIETY, FSB 2016-09-08 US disclosed
US-8236358-B1 Phosphate-binding magnesium salts and uses thereof CYPRESS PHARMACEUTICAL, INC. (US) 2012-08-07 US disclosed
US-20120195964-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2012-08-02 US disclosed
EP-2416786-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF Cypress Pharmaceutical, Inc. (US) 2012-02-15 EP disclosed
US-20110045063-A2 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2011-02-24 US disclosed
WO-2010117370-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed
US-20090269399-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2009-10-29 US disclosed